Abstract
Despite many programs aimed at better immediate care of cardiac arrest victims, the subsequent mortality rate remains high, with myocardial and central nervous system injuries as the most common causes of death. Preclinical research is badly needed to produce a sound base for future clinical trials and possible improvements in clinical outcome. Our continued use of a porcine model for studies of cerebral effects of anoxia and reperfusion has shown that this model results in standardized effects, where time of cardiac arrest and reperfusion are approximately proportional to the ischemic neurological injury. Free radical damage is proved to be an important pathophysiological mechanism in the early development of this nervous injury. Hence, not unexpectedly, early experimental treatment after total ischemia during early reperfusion results in improved measures of cerebral tissue damage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fredriksson M, Herlitz J, Engdahl J. Nineteen years’ experience of out-of-hospital cardiac arrest in Gothenburg – reported in Utstein style. Resuscitation. 2003 Jul; 58(1):37–47.
Herlitz J HS. Nationellt register för hjärtstopp utanför sjukhus (National register on cardiac arrests occurring outside hospitals). Gothenburg; 2004 Contract No.: Document Number|.
Wiklund L, Sharma HS, Basu S. Circulatory arrest as a model for studies of global ischemic injury and neuroprotection. Ann N Y Acad Sci. 2005 Aug;1053:205–219.
Bircher N, Safar P. Cerebral preservation during cardiopulmonary resuscitation. Crit Care Med. 1985; 13(3):185–190.
Mortberg E, Cumming P, Wiklund L, Rubertsson S. Cerebral metabolic rate of oxygen (CMRO2) in pig brain determined by PET after resuscitation from cardiac arrest. Resuscitation. 2009 Jun; 80(6):701–706.
Mortberg E, Cumming P, Wiklund L, Wall A, Rubertsson S. A PET study of regional cerebral blood flow after experimental cardiopulmonary resuscitation. Resuscitation. 2007 Oct; 75(1):98–104.
Sharma HS, Cervos-Navarro J. Brain oedema and cellular changes induced by acute heat stress in young rats. Acta Neurochir Suppl (Wien). 1990; 51:383–386.
Basu S, Nozari A, Liu XL, Rubertsson S, Wiklund L. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Lett. 2000; 470(1):1–6.
Miclescu A, Basu S, Wiklund L. Methylene blue added to a hypertonic-hyperoncotic solution increases short-term survival in experimental cardiac arrest. Crit Care Med. 2006 Nov; 34(11):2806–2813.
Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids. 1998; 58(4):319–325.
Basu S. Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids. 1998 May; 58(5):347–352.
Hossmann KA. Resuscitation potentials after prolonged global cerebral ischemia in cats. Crit Care Med. 1988; 16(10):964–971.
Hossmann KA. The hypoxic brain. Insights from ischemia research. Advances in Experimental Medicine and Biology. 1999; 474:155–69.
Rubertsson S, Grenvik A, Wiklund L. Blood flow and perfusion pressure during open-chest versus closed-chest cardiopulmonary resuscitation in pigs. Crit Care Med. 1995; 23(4):715–725.
Wiklund L, Soderberg D, Henneberg S, Rubertsson S, Stjernstrom H, Groth T. Kinetics of carbon dioxide during cardiopulmonary resuscitation. Crit Care Med. 1986; 14(12):1015–1022.
Schaafsma A, de Jong BM, Bams JL, Haaxma-Reiche H, Pruim J, Zijlstra JG. Cerebral perfusion and metabolism in resuscitated patients with severe post-hypoxic encephalopathy. J Neurol Sci. 2003 Jun 15; 210(1-2):23–30.
Toyoda K, Fujii K, Ibayashi S, Nagao T, Kitazono T, Fujishima M. Role of nitric oxide in regulation of brain stem circulation during hypotension. J Cereb Blood Flow Metab. 1997 Oct; 17(10):1089–1096.
Tsuchidate R, He QP, Smith ML, Siesjo BK. Regional cerebral blood flow during and after 2 hours of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1997 Oct; 17(10):1066–1073.
Ames A, 3rd, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol. 1968 Feb; 52(2):437–53.
Fischer EG, Ames A, 3rd, Lorenzo AV. Cerebral blood flow immediately following brief circulatory stasis. Stroke. 1979 Jul-Aug; 10(4):423–427.
Fischer M, Hossmann KA. No-reflow after cardiac arrest. Intensive Care Med. 1995;21(2):132–141.
Kagstrom E, Smith ML, Siesjo BK. Local cerebral blood flow in the recovery period following complete cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1983 Jun; 3(2):170–182.
Gaszynski W. Research work on blood clotting system during cardiorespiratory resuscitation. Anaesth Resusc Intensive Ther. 1974 Oct-Dec; 2(4):303–316.
Hekmatpanah J. Cerebral blood flow dynamics in hypotension and cardiac arrest. Neurology. 1973 Feb; 23(2):174–180.
Hossmann V, Hossmann KA, Takagi S. Effect of intravascular platelet aggregation on blood recirculation following prolonged ischemia of the cat brain. J Neurol. 1980 Jan; 222(3):159–170.
Geraghty MC, Torbey MT. Neuroimaging and serologic markers of neurologic injury after cardiac arrest. Neurol Clin. 2006 Feb; 24(1):107–121, vii.
Martin LJ, Brambrink A, Koehler RC, Traystman RJ. Primary sensory and forebrain motor systems in the newborn brain are preferentially damaged by hypoxia-ischemia. J Comp Neurol. 1997 Jan 13; 377(2):262–285.
Gedeborg R, Silander HC, Ronne-Engstrom E, Rubertsson S, Wiklund L. Adverse effects of high-dose epinephrine on cerebral blood flow during experimental cardiopulmonary resuscitation. Crit Care Med. 2000; 28(5):1423–1430.
Gedeborg R, Rubertsson S, Wiklund L. Improved haemodynamics and restoration of spontaneous circulation with constant aortic occlusion during experimental cardiopulmonary resuscitation. Resuscitation. 1999; 40(3):171–180.
Gedeborg R, Silander CsH, Rubertsson S, Wiklund L. Cerebral ischemia in experimental cardiopulmonary resuscitation - comparison of epinephrine and aortic occlusion. Resuscitation. 2001(50):319–329.
Nozari A, Rubertsson S, Wiklund L. Improved cerebral blood supply and oxygenation by aortic balloon occlusion combined with intra-aortic vasopressin administration during experimental cardiopulmonary resuscitation. Acta Anaesthesiol Scand. 2000; 44(10):1209–1219.
Lindner KH, Brinkmann A, Pfenninger EG, Lurie KG, Goertz A, Lindner IM. Effect of vasopressin on hemodynamic variables, organ blood flow, and acid-base status in a pig model of cardiopulmonary resuscitation. Anesth Analg. 1993; 77(3):427–435.
Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie KG. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet. 1997; 349(9051):535–537.
Nozari A, Rubertsson S, Wiklund L. Differences in the pharmacodynamics of epinephrine and vasopressin during and after experimental cardiopulmonary resuscitation. Resuscitation. 2001; 49(1):59–72.
Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004 Jan 8; 350(2):105–113.
Wik L, Kramer-Johansen JO, Myklebust H, Sørebø H, Svensson L, Fellows B, et al. Quality of cardiopulmonary resuscitation during out-of-hospital cardiac arrest. JAMA. 2005; 293:299–304.
Sunde K, Wik L, Steen PA. Quality of mechanical, manual standard and active compression-decompression CPR on the arrest site and during transport in a manikin model. Resuscitation. 1997 Jun; 34(3):235–242.
Hossmann KA. Reperfusion of the brain after global ischemia: hemodynamic disturbances. Shock (Augusta, Ga). 1997 Aug 8(2):95-101; discussion 2–3.
Fischer M, Dahmen A, Standop J, Hagendorff A, Hoeft A, Krep H. Effects of hypertonic saline on myocardial blood flow in a porcine model of prolonged cardiac arrest. Resuscitation. 2002 Sep; 54(3):269–280.
Ward KR MJ, Zelenak RR, Sullivan RJ, McSwain NE Jr. A comparison of chest compressions between mechanical and manual CPR by monitoring end-tidal PCO2 during human cardiac arrest. Ann Emerg Med. 1993; 22(4):669–674.
Rubertsson S KR. Increased cortical cerebral blood flow with LUCAS: a new device for mechanical chest compressions as compared to standard external compressions during experimental cardiopulmonary resuscitation. Resuscitation. 2005; In Press.
Steen S, Liao Q, Pierre L, Paskevicius A, Sjoberg T. Evaluation of LUCAS, a new device for automatic mechanical compression and active decompression resuscitation. Resuscitation. 2002 Dec; 55(3):285–299.
Basu S. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal. 2008 Aug; 10(8):1405–1434.
Basu S. Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation. Med Res Rev. 2007 Jul; 27(4):435–468.
Liu XL, Nozari A, Basu S, Ronquist G, Rubertsson S, Wiklund L. Neurological outcome after experimental cardiopulmonary resuscitation: A result of delayed and potentially treatable neuronal injury? Acta Anaesthesiologica Scandinavica. 2002; 46(5):537–546.
Liu XL, Wiklund L, Nozari A, Rubertsson S, Basu S. Differences in cerebral reperfusion and oxidative injury after cardiac arrest in pigs. Acta Anaesthesiol Scand. 2003 Sep; 47(8):958–967.
Basu S, Liu X, Nozari A, Rubertsson S, Miclescu A, Wiklund L. Evidence for time-dependent maximum increase of free radical damage and eicosanoid formation in the brain as related to duration of cardiac arrest and cardio-pulmonary resuscitation. Free Radic Res. 2003 Mar; 37(3):251–256.
Nozari A, Rubertsson S, Gedeborg R, Nordgren A, Wiklund L. Maximisation of cerebral blood flow during experimental cardiopulmonary resuscitation does not ameliorate post-resuscitation hypoperfusion. Resuscitation. 1999; 40(1):27–35.
Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol. 1993; 45(2):367–374.
Mayer B, Brunner F, Schmidt K. Novel actions of methylene blue. Eur Heart J. 1993;14 Suppl I:22–26.
Gruetter C, Kadowitz P, Ignarro L. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrate, and amyl nitrite. Can J Physiol Pharmacol. 1981; 59:150–156.
Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ. Relationship between cyclic guanosine 3,5-monophosphate formation and relaxation of coronary smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide, effects of methylene blue and methemoglobin. J Pharm Exp Therapeutics. 1981; 219:181–186.
Hay DW, Martin SA, Sugata R, Lichtin NN. Disproportionation of semimethylene blue and oxidation of leucomethylene blue by methylene blue and iron(III). Kinetics, equilibriums, and medium effects. J Phys Chem. 1981; 85:1474–1479.
Sevcik P, Dunford HB. Kinetics of the oxidation of NADH by methylene blue in a closed system. J Phys Chem. 1991; 95:2411–2415.
Johnstone MT, Lam JYT, Lacoste L, al. e. Methylene blue inhibits the antithrombotic effect of nitroglycerin. J Am Coll Cardiol. 1993; 20:255–259.
Diodati J, Theroux P, Latour JG, al e. Effect of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and unstable angina. Am J Cardiol. 1990; 66:683–688.
Schmidt HH, Pollock JS, Nakane M, Forstermann U, Murad F. Ca2+/calmodulin-regulated nitric oxide synthases. Cell Calcium. 1992; 13:427–434.
Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987; ii:1057–1058.
Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol. 1986; 88:411–415.
Shafer AI, Alexander RW, Handin RI. Inhibition of platelet function by organic nitrate vasodilators. Blood. 1980; 55:649–554.
Schroer K, Grodzinska L, Darius H. Stimulation of coronary vascular prostacyclin and inhibition of human platelet thromboxane A2 after low-dose nitroglycerin. Thrombosis Res. 1981; 23:59–67.
Salvemini D, Currie MG, Mollace V. Nitric oxide-mediated cyclooxygenase activation. J Clin Invest. 1996; 97:2562–2568.
Stamler JS, Loscalzo J. The antiplatelet effects of organic nitrates and related nitrous compounds in vivo and in vitro and their relevance to cardiovascular disorders. J Am Coll Cardiol. 1991; 18:1529–1536.
Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. NEJM. 1990; 323:27–36.
Wen FQ, Watanabe K, Yoshida M. Nitric oxide enhances PGI2 production by human pulmonary artery smooth muscle cells. Prostaglandins Leucotrienes Ess Fatty Cids. 2000; 62:369–378.
Tateson JE, Moncada S, Vane JR. Effects of prostacyclin (PGI) on cyclic AMP concentrations in human platelets. Prostaglandins. 1977; 13:389–397.
Levin RI, Jaffe EA, Weksler BB. Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells. J Clin Invest. 1981; 67:762–769.
Salaris SC, Babbs CF, Voorhees WD, 3rd. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. Biochem Pharmacol. 1991 Jul 15; 42(3):499–506.
Kelner MJ, Bagnell R, Hale B, Alexander NM. Potential of methylene blue to block oxygen radical generation in reperfusion injury. Basic Life Sci. 1988; 49:895–898.
Acknowledgment
Continued financial support over the years from The Laerdal Foundation for Acute Medicine is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Wiklund, L., Basu, S. (2011). An Experimental Model of Myocardial and Cerebral Global Ischemia and Reperfusion. In: Basu, S., Wiklund, L. (eds) Studies on Experimental Models. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-956-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-60761-956-7_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-955-0
Online ISBN: 978-1-60761-956-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)